Form 4 holding
Chief Executive Officer, Director
Galmed Pharmaceuticals Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 103,047
- Estimated value
- $86,559
- Report date
- 18 Mar 2026
- Price
- $0.8400
- Ownership
- Direct
Allen Baharaff
Insider Reports History
- Reporting-owner location
- Tel Aviv, Israel
- Latest reporting-owner signature
-
/s/ Allen Baharaff
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Allen Baharaff
Form 4 holding
Chief Executive Officer, Director
Galmed Pharmaceuticals Ltd.
- Security class
- Ordinary Shares
- Shares / value
- 18
- Estimated value
- $15
- Report date
- 18 Mar 2026
- Price
- $0.8400
- Ownership
- Indirect
Form 4 holding
Chief Executive Officer, Director
Galmed Pharmaceuticals Ltd.
- Security class
- Restricted Share Units
- Shares / value
- 100,000
- Estimated value
- Report date
- 18 Mar 2026
- Price
- Ownership
- Direct
Insider Reports Filed by Allen Baharaff
3
GLMD
Galmed Pharmaceuticals Ltd.
- Report period
- 18 Mar 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 18 Mar 2026, 07:45
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details